Archives
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Sulfo-NHS-Biotin: Precision Protein Labeling for Cell Sur...
2025-10-01
Sulfo-NHS-Biotin stands apart as a water-soluble biotinylation reagent, enabling selective cell surface protein labeling without membrane penetration. Its unmatched amine-reactivity and solubility streamline workflows in affinity chromatography, immunoprecipitation, and high-throughput single-cell proteomics—fueling advances in functional single-cell analysis and next-gen secretome profiling.
-
Dasatinib Monohydrate: ABL Kinase Inhibitor for Personali...
2025-09-30
Explore the advanced applications of Dasatinib Monohydrate, a multitargeted ABL kinase inhibitor, in dissecting drug resistance and tumor microenvironment complexity for chronic myeloid leukemia and beyond. This article offers a uniquely deep dive into integrating kinase inhibition with next-generation assembloid models.
-
A 83-01 in Human Organoid Pharmacokinetics: Beyond TGF-β ...
2025-09-29
Explore how A 83-01, a leading ALK-5 inhibitor, is advancing human organoid pharmacokinetics research by enabling precise control of TGF-β signaling. Discover unique insights into its mechanism, solubility, and pivotal role in next-generation drug metabolism modeling.
-
Sulfo-Cy3 Azide: Revolutionizing Live-Cell Developmental ...
2025-09-28
Discover how Sulfo-Cy3 azide, a sulfonated hydrophilic fluorescent dye, is setting a new standard for photostable, water-soluble Click Chemistry fluorescent labeling in live-cell developmental imaging. Explore advanced protocols and unique strategies that surpass conventional approaches.
-
KU-60019: Unlocking ATM Kinase Inhibition for Metabolic V...
2025-09-27
Discover how KU-60019, a selective ATM kinase inhibitor, unveils new metabolic vulnerabilities and enhances glioma radiosensitization. Explore unique mechanistic insights and translational implications for advanced cancer research.
-
CHIR 99021 Trihydrochloride: Unlocking GSK-3 Signaling in...
2025-09-26
Explore the unique applications of CHIR 99021 trihydrochloride, a potent GSK-3 inhibitor, in modulating stem cell fate and glucose metabolism. This article provides an advanced, comparative perspective on its role in next-generation organoid systems and metabolic disease modeling.
-
Amorolfine Hydrochloride: Illuminating Fungal Ploidy & Me...
2025-09-25
Explore the unique role of Amorolfine Hydrochloride as an antifungal reagent in dissecting fungal cell membrane integrity and ploidy constraints. This in-depth analysis connects molecular mechanisms to cutting-edge research applications, setting it apart in the field.
-
Panobinostat (LBH589): Unveiling PDAR and Beyond in Epige...
2025-09-24
Explore how Panobinostat (LBH589), a broad-spectrum hydroxamic acid-based histone deacetylase inhibitor, enables deep investigation into regulated apoptosis via the Pol II degradation-dependent apoptotic response (PDAR) and advanced epigenetic mechanisms. Gain novel insights that extend beyond classical HDAC inhibition for cancer and drug resistance research.
-
ISRIB (trans-isomer): Targeting ATF4 and eIF2B for Fibros...
2025-09-23
Explore how ISRIB (trans-isomer), a potent integrated stress response inhibitor, modulates ATF4 and eIF2B to advance ER stress research, apoptosis assays, and emerging models of liver fibrosis and neurodegeneration.
-
br Development of lorlatinib from crizotinib to a clinical
2025-03-03
Development of lorlatinib from crizotinib (1) to a clinical candidate (6) Xalkori (1, PF-02341066, crizotinib), was the first-in-class ALK inhibitor approved by the Unites States Food and Drug Administration (FDA) in 2011 as a first-line treatment for ALK+- NSCLC patients. This section describes
-
Blockers will reduce perioperative myocardial ischemia and s
2025-03-03
β-Blockers will reduce perioperative myocardial ischemia and studies published in the 1990s suggested that their routine administration before surgery provided protection against perioperative CV complications.31., 32., 33. Based on these early studies, several national organizations endorsed the pe
-
br Materials and methods br
2025-03-03
Materials and methods Results The average body weights for each group of mice over the course of the study are shown in Fig. 2A. The average body weights of the mice in the saline control group and PACAP group increased slightly during the study. In contrast, starting at day 17, the body weigh
-
In this study PRP positively regulated MIIP
2025-03-03
In this study, PRP4 positively regulated MIIP levels and significantly inhibited the invasion of HCT116 cells. Further investigations elucidated that PRP4 dephosphorylated MIIP via PP1A regulation, which was confirmed by PP1A inhibition in the presence of OA. Upon dephosphorylation, MIIP possibly i
-
br Conclusion The HT receptor family is
2025-03-03
Conclusion The 5-HT receptor family is complex, and one may ask as does Bryan Roth et al. [205] whether this is useless Rose Bengal (i.e. too much redundancy) or an embarrassment of the riches (i.e. many potential targets to choose from to affect normal or pathological function); molecular biolog
-
Similar to V the temporal
2025-03-03
Similar to V1, the temporal neocortex of mammals, including the primary auditory cortex (A1), is densely innervated by 5-HT fibers originating mainly in the dorsal raphe nucleus (Campbell et al., 1987, Harding and Paxinos, 2004, Törk, 1990), and the major W 54011 receptor of 5-HTRs are expressed th